Radiotherapy & Oncology
Volume 87, Issue 1 , Pages 3-16 , April 2008

The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature

  • Zheng Chen

      Affiliations

    • Queen’s Cancer Research Institute, Queen’s University, Kingston, Ont., Canada
    • ,
  • Will King

      Affiliations

    • Queen’s Cancer Research Institute, Queen’s University, Kingston, Ont., Canada
    • ,
  • Robert Pearcey

      Affiliations

    • Cross Cancer Institute, Edmonton, Alta., Canada
    • ,
  • Marc Kerba

      Affiliations

    • Queen’s Cancer Research Institute, Queen’s University, Kingston, Ont., Canada
    • ,
  • William J. Mackillop

      Affiliations

    • Queen’s Cancer Research Institute, Queen’s University, Kingston, Ont., Canada
    • Corresponding Author InformationCorresponding author. William J. Mackillop, Division of Cancer Care and Epidemiology, QCRI Level 2, Queen’s University, Kingston, Ont., Canada.

Received 12 July 2007 ,Revised 13 November 2007 ,Accepted 14 November 2007.

References 

  1. Klausen OG, Olofsson J, Rosengren B. A long waiting time for radiotherapy: not acceptable for patients with neoplasms. Tidsskr Nor Laegeforen. 1989;109:2324–2325
  2. Ash D, Barrett A, Hinks A, Squire C. Re-audit of radiotherapy waiting times 2003. Clin Oncol (R Coll Radiol). 2004;16:387–394
  3. Denham JW, Hamilton CS, Joseph DJ. How should a waiting list for treatment be managed?. Australas Radiol. 1992;36:274–275
  4. Anonymous. Radiotherapy services. Ministry of Health, New Zealand. N Z Health Hospital 1996;48:23–24.
  5. Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84:5–10
  6. Schafer C, Nelson K, Herbst M. Waiting for radiotherapy a national call for ethical discourse on waiting lists in radiotherapy: findings from a preliminary survey. Strahlenther Onkol. 2005;181:9–19
  7. Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys. 2003;56:319–327
  8. Gabriele P, Malinverni G, Bona C, Manfredi M, Delmastro E, Gatti M, et al. Are quality indicators for radiotherapy useful in the evaluation of service efficacy in a new based radiotherapy institution?. Tumori. 2006;92:496–502
  9. Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 1994;30:221–228
  10. Mackillop WJ, Zhou S, Groome P, Dixon P, Cummings BJ, Hayter C, et al. Changes in the use of radiotherapy in Ontario 1984–1995. Int J Radiat Oncol Biol Phys. 1999;44:355–362
  11. Mackillop WJ. Killing time: the consequences of delays in radiotherapy. Radiother Oncol. 2007;84:1–4
  12. Hall E, Giaccia AJ. Radiobiology for the radiologist. 6th ed.. Philadelphia (PA): Lippincott Williams & Wilkins; 2006;
  13. Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 1993;38:653–666
  14. Dubois JB, Salomon A, Gary-Bobo J, Pourquier H, Pujol H. Exclusive radical radiation therapy in breast carcinoma. Radiother Oncol. 1991;20:24–29
  15. Fletcher GH. Clinical dose response curves of human malignant epithelial tumours. Br J Radiol. 1973;46:151
  16. Overgaard J, Hansen HS, Jorgensen K, Hjelm Hansen M. Primary radiotherapy of larynx and pharynx carcinoma–an analysis of some factors influencing local control and survival. Int J Radiat Oncol Biol Phys. 1986;12:515–521
  17. Perez CA, Grigsby PW, Nene SM, Camel HM, Galakatos A, Kao MS, et al. Effect of tumor size on the prognosis of carcinoma of the uterine cervix treated with irradiation alone. Cancer. 1992;69:2796–2806
  18. Sutcliffe SB, Gospodarowicz MK, Bush RS, Brown TC, Chua T, Bean HA, et al. Role of radiation therapy in localized non-Hodgkin’s lymphoma. Radiother Oncol. 1985;4:211–223
  19. Spratt JS, Meyer JS, Spratt JA. Rates of growth of human neoplasms: Part II. J Surg Oncol. 1996;61:68–83
  20. Friberg S, Mattson S. On the growth rates of human malignant tumors: implications for medical decision making. J Surg Oncol. 1997;65:284–297
  21. Shackney SE, McCormack GW, Cuchural GJ. Growth rate patterns of solid tumors and their relation to responsiveness to therapy: an analytical review. Ann Intern Med. 1978;89:107–121
  22. Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS, Raaymakers CP, et al. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66:271–276
  23. Mackillop WJ, Bates JH, O’Sullivan B, Withers HR. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34:243–250
  24. Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1989;95:2S–4S
  25. Sanmartin C, Shortt SE, Barer ML, Sheps S, Lewis S, McDonald PW. Waiting for medical services in Canada: lots of heat, but little light. CMAJ. 2000;162:1305–1310
  26. Bardell T, Belliveau P, Kong W, Mackillop WJ. Waiting times for cancer surgery in Ontario: 1984–2000. Clin Oncol (R Coll Radiol). 2006;18:401–409
  27. Levy AR, Sobolev BG, Hayden R, Kiely M, Fitzgerald JM, Schechter MT. Time on wait lists for coronary bypass surgery in British Columbia, Canada, 1991–2000. BMC Health Serv Res. 2005;5:22
  28. Hatch WV, Trope GE. Waiting times for eye surgery at a Toronto teaching hospital. Can J Ophthalmol. 2004;39:31–37
  29. Ipsos News Centre. Canadians agree that a patient wait time guarantee is the most important priority for Canada’s New Government. 11.29.2006.
  30. Health Canada. Backgrounder on Wait Times. <http://hc-sc.gc.ca/ahc-asc/media/nr-cp/2005/2005_81bk1_e.html> November 30, 2007.
  31. Joshi NP, Noseworthy FT, Noseworthy TW. Waiting time care guarantees: necessity or nemesis?. Health Manage Forum. 2006;19:35–39
  32. Huang J, Barbera L, Brouwers M, Browman G, Mackillop WJ. Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. J Clin Oncol. 2003;21:555–563
  33. Benk V, Fisher A, Glazer D, Paszat L. Impact of radiation wait times on risk of local recurrence of breast cancer: early stage cancer with no chemotherapy.Ottawa: Canadian Coordinating Office for Health Technology Assessment <http://www.cadth.ca/index.php/en/publication/466> November 30, 2007.
  34. Fietkau R. Effects of the time interval between surgery and radiotherapy on the treatment results. Strahlenther Onkol. 2000;176:452–457
  35. Ruo Redda MG, Verna R, Guarneri A, Sannazzari GL. Timing of radiotherapy in breast cancer conserving treatment. Cancer Treat Rev. 2002;28:5–10
  36. Heimüller R. L’effet du délai de la radiothérapie adjuvante sans chimiothérapie sur les résultats du traitement conservateur du sein: revue systématique. Montréal: Agence d’évaluation des technologies et des modes d’intervention en santé. 2006;
  37. Hebert-Croteau N, Freeman CR, Latreille J, Brisson J. Delay in adjuvant radiation treatment and outcomes of breast cancer–a review. Breast Cancer Res Treat. 2002;74:77–94
  38. Greenland S. Meta analysis. In: Rothman KJ, Greenland S, editors. Modern epidemiology. 2nd ed. Philadelphia: Lippincott-Raven Publishers; 1998. p. 643–73.
  39. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose–response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–1309
  40. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560
  41. Higgins JP, Thompson S. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558
  42. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. [updated September 2006]. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd.
  43. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634
  44. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics. 2000;56:455–463
  45. Duval S, Tweedie R. A nonparametric “Trim and Fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc. 2000;95:89–98
  46. Fourquet A, Dreyfus H, Colombani H, Maher M, Gozy M, Campana F, et al. Influence of surgery-radiotherapy interval on recurrence in breast-conserving treatment of small breast cancer. Int J Radiation Oncol Biol Phys. 1995;32(Suppl):260
  47. Whelan TJ, Clark RM, Levine MN, Willan A, McCulloch P, Lipa M, et al. The effect of delay in initiating radiotherapy post-lumpectomy on local breast recurrence. In J Radiat Oncol Biol Phys. 1996;36:280
  48. Clarke DH, Le MG, Sarrazin D, Lacombe MJ, Fontaine F, Travagli JP, et al. Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys. 1985;11:137–145
  49. Vujovic O, Perera F, Dar AR, Stitt L, Yu E, Voruganti SM, et al. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?. Int J Radiat Oncol Biol Phys. 1998;40:869–874
  50. Froud PJ, Mates D, Jackson JS, Phillips N, Andersen S, Jackson SM, et al. Effect of time interval between breast-conserving surgery and radiation therapy on ipsilateral breast recurrence. Int J Radiat Oncol Biol Phys. 2000;46:363–372
  51. Ampil FL, Burton GV, Li BD, Mills GM. Radiotherapy with and without chemotherapy after breast conservation surgery for early stage breast cancer: a review of timing. Eur J Gynaecol Oncol. 1999;20:254–257
  52. Bahena J, Labastida Almendaro S, Ayala Hernandez JR, Fernandez Orozco A. Impact of the interval between surgery and radiotherapy in the initial phases of breast cancer in patients who did not receive systemic adjuvant therapy. Ginecol Obstet Mex. 1998;66:87–91
  53. Nixon AJ, Recht A, Neuberg D, Connolly JL, Schnitt S, Abner A, et al. The relation between the surgery-radiotherapy interval and treatment outcome in patients treated with breast-conserving surgery and radiation therapy without systemic therapy. Int J Radiat Oncol Biol Phys. 1994;30:17–21
  54. Slotman BJ, Meyer OW, Njo KH, Karim AB. Importance of timing of radiotherapy in breast conserving treatment for early stage breast cancer. Radiother Oncol. 1994;30:206–212
  55. Hartsell WF, Recine DC, Griem KL, Murthy AK. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer. 1995;76:2497–2503
  56. Buchholz TA, Austin-Seymour MM, Moe RE, Ellis GK, Livingston RB, Pelton JG, et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys. 1993;26:23–35
  57. Recht A, Come SE, Gelman RS, Goldstein M, Tishler S, Gore SM, et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol. 1991;9:1662–1667
  58. Leonard CE, Wood ME, Zhen B, Rankin J, Waitz DA, Norton L, et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?. J Clin Oncol. 1995;13:2906–2915
  59. Meek AG, Park TL, Weiss TA, Bethune WA. Effect of delayed radiation therapy on local control in breast conservation therapy. Radiology. 1996;200:615–619
  60. McCormick B, Norton L, Yao TJ, Yahalom J, Petrek JA. The impact of the sequence of radiation and chemotherapy on local control after breast-conserving surgery. Cancer J Sci Am. 1996;2:39–45
  61. Recht A, Come SE, Henderson IC, Gelman RS, Silver B, Hayes DF, et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med. 1996;334:1356–1361
  62. O’Sullivan B, Mackillop W, Grice B, Goh C, Rothwell D, Warde P, et al. The influence of delay in the initiation of definitive radiotherapy in carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys. 1998;42(Suppl):323
  63. Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52:929–936
  64. Lee AW, Chan DK, Fowler JF, Poon YF, Law SCK, Foo W, et al. T1 nasopharyngeal carcinoma: the effect of waiting time on tumor control. Int J Radiat Oncol Biol Phys. 1994;30:1111–1117
  65. Brouha XD, Op de Coul B, Terhaard CH, Hordijk GJ. Does waiting time for radiotherapy affect local control of T1N0M0 glottic laryngeal carcinoma?. Clin Otolaryngol. 2000;25:215–218
  66. Barton MB, Morgan G, Smee R, Tiver KW, Hamilton C, Gebski V. Does waiting time affect the outcome of larynx cancer treated by radiotherapy?. Radiother Oncol. 1997;44:137–141
  67. Dixit S, Vyas RK, Toparani RB, Baboo HA, Patel DD. Surgery versus surgery and postoperative radiotherapy in squamous cell carcinoma of the buccal mucosa: a comparative study. Ann Surg Oncol. 1998;5:502–510
  68. Kajanti M, Holsti LR, Holsti P. Radical surgery and postoperative split-course radiotherapy in squamous cell carcinoma of the mobile tongue: factors influencing local control and the time to recurrence. Radiother Oncol. 1991;22:174–179
  69. Trotti A, Klotch D, Endicott J, Ridley M, Greenberg H. A prospective trial of accelerated radiotherapy in the postoperative treatment of high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 1993;26:13–21
  70. Ampil FL, Buechter KJ, Bairnsfather LE, Shockley WW. Timing and dosage of postoperative radiotherapy for squamous cell carcinoma of the upper aerodigestive tract. J Oral Maxillofac Surg. 1993;51:1194–1197
  71. Ampil FL, Burton GV, Mills GM. Cranial irradiation in patients with brain metastasis: a retrospective study of timing. Radiat Med. 1999;17:271–273
  72. Wurschmidt F, Bunemann H, Ehnert M, Heilmann HP. Is the time interval between surgery and radiotherapy important in operable nonsmall cell lung cancer? A retrospective analysis of 340 cases. Int J Radiat Oncol Biol Phys. 1997;39:553–559
  73. Do V, Gebski V, Barton MB. The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol. 2000;57:131–136
  74. Wallgren A, Bernier J, Gelber RD, Goldhirsch A, Roncadin M, Joseph D, et al. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group. Int J Radiat Oncol Biol Phys. 1996;35:649–659
  75. Schiff PB, Harrison LB, Strong EW, Fass DE, Shah JP, Spiro R, et al. Impact of the time interval between surgery and postoperative radiation therapy on locoregional control in advanced head and neck cancer. J Surg Oncol. 1990;43:203–208
  76. Benk V, Joseph L, Fortin P, Zhang G, Belisle P, Levinton C, et al. Effect of delay in initiating radiotherapy for patients with early stage breast cancer. Clin Oncol (R Coll Radiol ). 2004;16:6–11
  77. Hebert-Croteau N, Freeman CR, Latreille J, Rivard M, Brisson J. A population-based study of the impact of delaying radiotherapy after conservative surgery for breast cancer. Breast Cancer Res Treat. 2004;88:187–196
  78. Mikeljevic JS, Haward R, Johnston C, Crellin A, Dodwell D, Jones A, et al. Trends in postoperative radiotherapy delay and the effect on survival in breast cancer patients treated with conservation surgery. Br J Cancer. 2004;90:1343–1348
  79. Yock TI, Taghian AG, Kachnic LA, Coen JJ, Assaad SI, Powell SN. The effect of delaying radiation therapy for systemic chemotherapy on local-regional control in breast cancer. Breast Cancer Res Treat. 2004;84:161–171
  80. Marshak G, Rakowsky E, Schachter J, Shvero J, Feinmesser R, Sulkes A, et al. Is the delay in starting postoperative radiotherapy a key factor in the outcome of advanced (T3 and T4) laryngeal cancer?. Otolaryngol Head Neck Surg. 2004;131:489–493
  81. Suwinski R, Sowa A, Rutkowski T, Wydmanski J, Tarnawski R, Maciejewski B. Time factor in postoperative radiotherapy: a multivariate locoregional control analysis in 868 patients. Int J Radiat Oncol Biol Phys. 2003;56:399–412
  82. Leon X, de Vega M, Orus C, Moran J, Verges J, Quer M. The effect of waiting time on local control and survival in head and neck carcinoma patients treated with radiotherapy. Radiother Oncol. 2003;66:277–281
  83. Choan E, Dahrouge S, Samant R, Mirzaei A, Price J. Radical radiotherapy for cervix cancer: the effect of waiting time on outcome. Int J Radiat Oncol Biol Phys. 2005;61:1071–1077
  84. Ballo MT, Zagars GK, Cormier JN, Hunt KK, Feig BW, Patel SR, et al. Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004;58:1461–1467
  85. Schwartz DL, Einck J, Hunt K, Bruckner J, Conrad E, Koh WJ, et al. The effect of delayed postoperative irradiation on local control of soft tissue sarcomas of the extremity and torso. Int J Radiat Oncol Biol Phys. 2002;52:1352–1359
  86. Nguyen TD, Naja A, Chaplalin G, Mere P. Influence du délai entre la chirurgie et I‘irradiation locorégionale sur I‘évolution des cancers du sein N+ non métastatiques: Une étude du Groupe des radiothérapeutes de la Fédération nationale des centres de lutte contre le cancer. Bull Cancer Radiother. 1993;80:229–233
  87. Metz JM, Schultz DJ, Fox K, Mathews A, Glick J, Solin LJ. Analysis of outcomes for high-risk breast cancer based on interval from surgery to postmastectomy radiation therapy. Cancer J. 2000;6:324–330
  88. Hansen O, Larsen S, Bastholt L, Godballe C, Jorgensen KE. Duration of symptoms: impact on outcome of radiotherapy in glottic cancer patients. Int J Radiat Oncol Biol Phys. 2005;61:789–794
  89. von Fournier D, Weber E, Hoeffken W, Bauer M, Kubli F, Barth V. Growth rate of 147 mammary carcinomas. Cancer. 1980;45:2198–2207
  90. Sackett DL, Haynes BR, Guyatt GH, Tugwell P. Clinical Epidemiology: A Basic Science for Clinical Medicine. 2nd ed. Boston: Little Brown; 1991.
  91. Mackillop WJ. The clinical consequences of delays in radiotherapy. Editorial. Radiother Oncol, 2007.
  92. Hill AB. The environment and disease: association or causation?. Proc R Soc Med. 1965;58:295–300

PII: S0167-8140(07)00588-9

doi: 10.1016/j.radonc.2007.11.016

Radiotherapy & Oncology
Volume 87, Issue 1 , Pages 3-16 , April 2008

Article Tools

* Image Usage & Resolution